Celgene (CELG) Rating Lowered to C+ at TheStreet

Olive Hawkins
Декабря 7, 2017

The stock increased 2.01% or $0.3716 during the last trading session, reaching $18.9016. Considering that the stock daily volume of 4.28 million shares, this represents a pretty noteworthy trading in volume size. Washington Real Estate Investment Trust (WRE) has risen 15.41% since December 7, 2016 and is uptrending. It has outperformed by 17.04% the S&P500. Envestnet Asset Management Incorporated holds 176,782 shares. Calamos Wealth Management Lc has invested 0.34% in Celgene Corporation (NASDAQ:CELG). Sowell Financial Services LLC now owns 2,454 shares of the biopharmaceutical company's stock valued at $289,000 after purchasing an additional 13 shares in the last quarter. Celgene Corporation now has $80.44 billion valuation. (NYSE:CEI) traded down -3.44% in the last session while performance was up 0.16% in the last five days. About 85,372 shares traded. Histogenics Corporation (NASDAQ:HSGX) has declined 7.61% since December 3, 2016 and is downtrending. It has outperformed by 0.30% the S&P500. One investment analyst has rated the stock with a sell rating, eleven have assigned a hold rating, nineteen have given a buy rating and two have issued a strong buy rating to the company's stock. Therefore 0 are positive. Sumitomo Mitsui reported 2.45M shares. The firm has "Sell" rating given on Wednesday, July 13 by Berenberg.

On Wednesday, November 29th, Corp /De/ Celgene sold 4,263 shares of Crispr Therapeutics stock. The stock of JPMorgan Chase & Co. The rating was maintained by RBC Capital Markets on Friday, July 28 with "Hold". The company was maintained on Wednesday, February 24 by Jefferies.

Investors sentiment increased to 1.34 in Q2 2017. Its up 0.14, from 1.05 in 2017Q1. Zwj Invest Counsel invested in 220,397 shares. 34 funds opened positions while 99 raised stakes. 7,049 are held by Edgewood Llc. The company has market cap of $2.46 billion. Reilly Financial Advsrs Ltd Co owns 48,741 shares or 0.28% of their United States portfolio. Keating Investment Counselors Inc reported 7,084 shares. The company holds 805.20 million outstanding shares and 785.31 million shares are floating in market. Bp Plc holds 112,000 shares. Sg Americas reported 39,235 shares. Mastrapasqua Asset Mngmt Inc holds 1.88% or 67,035 shares in its portfolio. (NYSE:JPM). Birch Hill Inv Advsr Limited Co holds 0.78% in JPMorgan Chase & Co. Taurus Asset Ltd reported 209,205 shares stake.

The Piotroski score is a discrete score ranging from 0-9 that shows nine criteria used to find out the strength of a company's financial position.

Among 29 analysts covering AT&T Inc. (NYSE:FII) to report earnings on January, 25.

CELGs average Altman Z-Score: 4.02 in the past 7 years. After $1.78 actual EPS reported by Celgene Corporation for the previous quarter, Wall Street now forecasts -2.25% negative EPS growth. Redwood Investments Ltd holds 1.63% or 124,460 shares. Howe And Rusling owns 30,146 shares. Inc (NYSE:BBY) by 319,400 shares to 113,400 shares, valued at $6.50 million in 2017Q2, according to the filing. Amgen Inc (NASDAQ:AMGN) was raised too.

Читайте также: Viagra goes generic: Pfizer to launch own little white pill

In other Celgene news, Director Gilla Kaplan sold 9,250 shares of the firm's stock in a transaction dated Tuesday, September 12th. Therefore 65% are positive. The firm's quarterly revenue was up 10.2% on a year-over-year basis. analysts anticipate that Celgene Corporation will post 6.67 EPS for the current fiscal year. Oppenheimer set a $166.00 price objective on shares of Celgene and gave the stock a buy rating in a research note on Thursday, November 16th. The company now has an average rating of Buy and a consensus price target of $139.57. $575,038 worth of Celgene Corporation (NASDAQ:CELG) was sold by VESSEY RUPERT on Thursday, June 15. BMO Capital Markets upped their price target on Celgene from $148.00 to $155.00 and gave the stock an "outperform" rating in a research note on Friday, November 17th. Moreover, Northeast Mngmt has 1.56% invested in Celgene Corporation (NASDAQ:CELG) for 132,240 shares. SunTrust maintained the shares of CELG in report on Friday, October 27 with "Buy" rating. The rating was maintained by Jefferies on Thursday, September 14 with "Buy". The company was maintained on Friday, October 20 by Leerink Swann.

Investors sentiment decreased to 0.86 in 2017 Q2. The firm has a market capitalization of $80,416.56, a P/E ratio of 15.96, a PEG ratio of 0.79 and a beta of 1.78. It is positive, as 60 investors sold Celgene Corporation shares while 390 reduced holdings.

A number of other institutional investors and hedge funds have also recently made changes to their positions in CELG. The biopharmaceutical company reported $1.68 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $1.47 by $0.21.

Celgene (NASDAQ CELG) traded down $0.39 during trading hours on Friday, reaching $102.17. Da Davidson Company has 52,163 shares for 0.15% of their portfolio. 5,000 shares were sold by Friedman Michael A, worth $625,000. Sectoral Asset Mngmt owns 233,768 shares. They expect $1.74 earnings per share, up 23.40% or $0.33 from last year's $1.41 per share. Utd Automobile Association invested in 0.33% or 842,022 shares. Canaccord Genuity set a $140.00 price target on shares of Celgene and gave the company a buy rating in a research report on Thursday, November 16th. Wells Fargo Mn reported 0.29% stake. Garrison Bradford Associate holds 8.09% in Celgene Corporation (NASDAQ:CELG) or 71,970 shares. Appleton Incorporated Ma holds 12,062 shares or 0.26% of its portfolio.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

При любом использовании материалов сайта и дочерних проектов, гиперссылка на обязательна.
«» 2007 - 2017 Copyright.
Автоматизированное извлечение информации сайта запрещено.

Код для вставки в блог

Other reports by

Discuss This Article